{
  "id": "NCLEXRN_NGN_OR_26_001",
  "questionType": "orderedResponse",
  "stem": "The nurse is caring for an 82-year-old client admitted for altered mental status and weakness. The nurse has just received the morning laboratory results and the cardiology interpretation of the 12-lead ECG. Based on the complete clinical picture presented in the exhibits, in what order should the nurse perform the following actions? Drag and drop the actions from the left to the correct sequence on the right, from highest to lowest priority.",
  "exhibits": [
    {
      "id": "exhibit_1",
      "type": "NursesNotes",
      "content": "Client is an 82-year-old male with a history of heart failure (HF), chronic kidney disease (CKD) Stage 3, and hypertension. Admitted from home after his daughter found him lethargic and confused. Daughter states, 'He seemed fine yesterday, but today he's nauseous and sees yellow halos around the lights.' She also mentioned he may have missed several doses of his furosemide this week because 'the pharmacy had a problem with his refill.' On assessment at 0900, client is lethargic but arousable to voice. Skin is cool and dry. Apical pulse is irregular. Abdomen is soft with hypoactive bowel sounds."
    },
    {
      "id": "exhibit_2",
      "type": "VitalSigns",
      "content": [
        {
          "time": "0800",
          "hr": "52",
          "bp": "104/62",
          "rr": "18",
          "temp": "36.8°C (98.2°F)",
          "spo2": "95% on room air"
        },
        {
          "time": "0900",
          "hr": "48",
          "bp": "98/58",
          "rr": "16",
          "temp": "36.7°C (98.1°F)",
          "spo2": "96% on room air"
        }
      ]
    },
    {
      "id": "exhibit_3",
      "type": "LabResults",
      "content": [
        {
          "lab": "Potassium (K+)",
          "value": "7.1 mEq/L",
          "reference": "3.5-5.0 mEq/L"
        },
        {
          "lab": "Creatinine",
          "value": "3.8 mg/dL",
          "reference": "0.6-1.2 mg/dL"
        },
        {
          "lab": "BUN",
          "value": "88 mg/dL",
          "reference": "10-20 mg/dL"
        },
        {
          "lab": "Digoxin Level",
          "value": "3.2 ng/mL",
          "reference": "0.5-2.0 ng/mL"
        },
        {
          "lab": "Troponin T",
          "value": "<0.01 ng/mL",
          "reference": "<0.04 ng/mL"
        }
      ]
    },
    {
      "id": "exhibit_4",
      "type": "DiagnosticFinding",
      "title": "ECG Interpretation",
      "content": "Sinus bradycardia with first-degree AV block. Rate 49 bpm. QRS complex is wide (0.14 seconds). Peaked T-waves noted in precordial leads. ST segment depression with a 'scooped' appearance observed."
    },
    {
      "id": "exhibit_5",
      "type": "MAR",
      "title": "Provider Orders",
      "content": [
        {
          "medication": "Calcium Gluconate 1 gram IV over 5 minutes",
          "frequency": "STAT"
        },
        {
          "medication": "Regular Insulin 10 units IV Push",
          "frequency": "STAT"
        },
        {
          "medication": "Dextrose 50% 25 grams IV Push",
          "frequency": "STAT, give after Insulin"
        },
        {
          "medication": "Sodium Polystyrene Sulfonate 15 grams PO",
          "frequency": "STAT"
        },
        {
          "medication": "Digoxin 0.125 mg PO",
          "frequency": "Daily"
        }
      ]
    }
  ],
  "options": [
    {
      "id": "opt_5",
      "content": "Withhold the scheduled daily dose of digoxin."
    },
    {
      "id": "opt_2",
      "content": "Withhold the ordered STAT dose of calcium gluconate."
    },
    {
      "id": "opt_1",
      "content": "Place the client on continuous cardiac monitoring."
    },
    {
      "id": "opt_3",
      "content": "Contact the provider to report critical lab values and recommend an order for digoxin immune Fab."
    },
    {
      "id": "opt_4",
      "content": "Administer STAT regular insulin and dextrose 50% IV."
    }
  ],
  "correctResponse": [
    "opt_1",
    "opt_2",
    "opt_5",
    "opt_3",
    "opt_4"
  ],
  "rationale": {
    "correct": "The correct sequence prioritizes immediate safety, preventing iatrogenic harm, communicating critical findings, and then implementing appropriate medical interventions. The client is experiencing life-threatening hyperkalemia (K+ 7.1 mEq/L) with ECG changes, AND concurrent digoxin toxicity (level 3.2 ng/mL) with classic signs (bradycardia, visual changes, GI upset, AV block). The 'Safety Stop' is recognizing that administering calcium gluconate in the presence of digoxin toxicity is contraindicated and can precipitate a fatal dysrhythmia ('stone heart') due to the synergistic effects of calcium and digitalis on myocardial contractility and conduction. Therefore, the nurse's first action is to ensure continuous monitoring. The next actions are to withhold the dangerous medication (calcium) and the medication causing the toxicity (digoxin). Then, the nurse must urgently communicate the full clinical picture to the provider and advocate for the antidote. Finally, the nurse can proceed with the safe component of the hyperkalemia protocol (insulin/dextrose) which will begin to lower the potassium level.\n\n**Pathophysiology Rationale:**\n*   **Hyperkalemia:** Elevated potassium levels disrupt the normal resting membrane potential of cardiac cells, leading to impaired repolarization and potentially fatal arrhythmias like ventricular fibrillation or asystole. The peaked T waves and widened QRS complex on the ECG are manifestations of this disruption.\n*   **Digoxin Toxicity:** Digoxin inhibits the sodium-potassium ATPase pump, leading to increased intracellular sodium and calcium. In toxic levels, this can cause excessive calcium influx into myocardial cells, increasing contractility but also increasing the risk of afterdepolarizations and arrhythmias. The scooped ST segment depression is a classic sign of digoxin effect/toxicity.\n*   **Calcium Gluconate Contraindication:** In digoxin toxicity, administering calcium gluconate further increases intracellular calcium levels, potentially leading to a 'stone heart' effect – a state of sustained myocardial contraction and fatal arrhythmia.",
    "incorrect": "Any sequence that administers calcium gluconate is incorrect and potentially fatal. Any sequence that delays placing the client on a cardiac monitor fails to address the most immediate life-threat. Administering insulin/dextrose before recognizing and acting on the contraindication is a plausible but incorrect sequence, as it misses the critical 'stop and think' step that defines safe practice. Delaying communication with the provider after identifying a life-threatening contraindication is also unsafe.",
    "answerBreakdown": [
      {
        "label": "First Action",
        "content": "Place the client on continuous cardiac monitoring.",
        "isCorrect": true,
        "rationale": "This is the highest priority. The combination of severe hyperkalemia and digoxin toxicity places the client at extreme risk for fatal cardiac arrhythmias. Continuous monitoring is essential for immediate detection of decompensation and to evaluate the effects of any intervention. This is a foundational safety action. **Pathophysiology:** Continuous monitoring allows for immediate detection of arrhythmias caused by hyperkalemia and digoxin toxicity, such as ventricular tachycardia or bradycardia, enabling prompt intervention to prevent cardiac arrest."
      },
      {
        "label": "Second Action",
        "content": "Withhold the ordered STAT dose of calcium gluconate.",
        "isCorrect": true,
        "rationale": "This is the critical 'STOP' action. The nurse must recognize the absolute contraindication. Administering IV calcium to a client with digoxin toxicity can cause a massive influx of calcium into myocardial cells, leading to severe ventricular dysrhythmias and asystole. Preventing this iatrogenic event is the most important clinical judgment after establishing monitoring. **Pathophysiology:** Digoxin toxicity increases intracellular calcium. Administering calcium gluconate further elevates intracellular calcium, leading to excessive myocardial contractility and potentially fatal arrhythmias."
      },
      {
        "label": "Third Action",
        "content": "Withhold the scheduled daily dose of digoxin.",
        "isCorrect": true,
        "rationale": "This is another crucial 'STOP' action. The client is already toxic. Administering another dose would worsen the toxicity and increase the risk of cardiac arrest. This must be done before contacting the provider as an immediate, independent nursing safety action. **Pathophysiology:** Continuing digoxin administration exacerbates the existing toxicity by further inhibiting the Na+/K+ ATPase pump, leading to increased intracellular sodium and calcium, and increasing the risk of arrhythmias."
      },
      {
        "label": "Fourth Action",
        "content": "Contact the provider to report critical lab values and recommend an order for digoxin immune Fab.",
        "isCorrect": true,
        "rationale": "After ensuring immediate safety by monitoring and withholding harmful medications, the nurse must communicate urgently. This SBAR-style communication should include all critical data (K+, creatinine, digoxin level, ECG) and the nurse's concern about the calcium order. Advocating for the antidote, digoxin immune Fab, is a key professional responsibility. **Pathophysiology:** Digoxin immune Fab (Digibind) binds to digoxin, preventing it from binding to the Na+/K+ ATPase pump and reversing the toxic effects. Prompt administration is crucial to prevent further cardiac complications."
      },
      {
        "label": "Fifth Action",
        "content": "Administer STAT regular insulin and dextrose 50% IV.",
        "isCorrect": true,
        "rationale": "This is the first safe medical intervention to actively treat the hyperkalemia. Insulin temporarily shifts potassium from the extracellular fluid into the cells, lowering the serum potassium level and stabilizing the cardiac membrane potential. It is safe to give in this scenario and should be done after addressing the contraindication and communicating with the provider. **Pathophysiology:** Insulin stimulates the Na+/K+ ATPase pump, promoting the movement of potassium from the extracellular fluid into the intracellular space, thereby lowering serum potassium levels. Dextrose is administered concurrently to prevent hypoglycemia."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Physiological Adaptation",
    "nclexSubcategory": "Hemodynamics, Medical Emergencies",
    "secondaryCategory": "Safety and Infection Control",
    "secondarySubcategory": "Medication Administration, Error Prevention",
    "difficulty": "5",
    "topicTags": [
      "Hyperkalemia",
      "Digoxin Toxicity",
      "Medication Safety",
      "Contraindication",
      "Acute Kidney Injury",
      "Prioritization",
      "Ordered Response"
    ]
  },
  "sbar": {
    "situation": "At 0900, an 82-year-old male admitted for altered mental status and weakness is exhibiting signs of hyperkalemia and digoxin toxicity. He has a history of heart failure (HF), chronic kidney disease (CKD) Stage 3, and hypertension.",
    "background": "The client was found lethargic and confused by his daughter, who reports possible missed doses of furosemide. Assessment reveals lethargy, cool and dry skin, irregular apical pulse, and hypoactive bowel sounds. Vital signs at 0900: HR 48 bpm, BP 98/58 mmHg.",
    "assessment": "Critical lab values include: Potassium 7.1 mEq/L, Creatinine 3.8 mg/dL, BUN 88 mg/dL, and Digoxin level 3.2 ng/mL. ECG shows sinus bradycardia with first-degree AV block, wide QRS complex (0.14 seconds), peaked T-waves, and ST segment depression. An order is present for Calcium Gluconate 1 gram IV STAT.",
    "recommendation": "I recommend withholding the STAT calcium gluconate and the scheduled digoxin dose, initiating continuous cardiac monitoring, contacting you to discuss the critical lab values and the need for digoxin immune Fab, and then administering STAT regular insulin and dextrose 50% IV per protocol for hyperkalemia."
  },
  "clinicalPearls": [
    "Calcium gluconate is contraindicated in digoxin toxicity due to the risk of 'stone heart' (severe ventricular dysrhythmias and asystole).",
    "Visual disturbances (e.g., yellow halos) are a classic sign of digoxin toxicity.",
    "Hyperkalemia and digoxin toxicity can cause life-threatening cardiac arrhythmias. Continuous cardiac monitoring is essential.",
    "When faced with conflicting orders, the nurse must prioritize patient safety and question orders that could be harmful.",
    "SBAR communication is crucial for effectively conveying critical information to the provider."
  ],
  "sentinelStatus": "healed_v2026_v8"
}